NCT06676527 2025-12-05
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Recruiting
Jinling Hospital, China
Tampere University Hospital
Centre Hospitalier Universitaire de Tivoli
Emory University
Emory University
M.D. Anderson Cancer Center